© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
Pediatrics
American Academy of Pediatrics Issues Annual Influenza Season Recommendations
September 19, 2020
The American Academy of Pediatrics (AAP) has issued its recommendations for the 2020-2021 influenza season.
FDA OKs Hybrid Closed Loop Diabetes Management Device for Use in Young Children
September 01, 2020
The MiniMed 770G system (Medtronic) is approved for use by individuals aged 2 to 6 with type 1 diabetes.
NACDS Urges Further State Action to Affirm Pharmacist-Administered Childhood Vaccinations
August 27, 2020
NACDS is urging states to provide clarity on pharmacist-provided childhood vaccinations, and enhance overall patient access to vaccines.
Pharmacy Groups Voice Support for Pharmacist-Provided Childhood Vaccines After AAP Opposition
August 24, 2020
Twelve pharmacy organization issued a joint statement in response to the expansion of the pharmacist's role in providing vaccines to children.
Pandemic Presents Unique Challenges for ADHD Management
August 20, 2020
Caregivers of children with ADHD can choose from an increasing number of treatments that can be customized.
FDA OKs New Treatment for Seizures Associated with Dravet Syndrome
June 26, 2020
Officials with the FDA approved fenfluramine (Fintepla, Zogenix) oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.
Children’s Cough Relief Products Recalled for Wrong Dosing Cups
June 23, 2020
The FDA warned that the dosing cups, which were missing some graduation markings, could cause an accidental overdose.
Gilead Announces Plans for Pediatric COVID-19 Trial of Remdesivir
June 18, 2020
The phase 2/3 trials will evaluate remdesivir (Gilead) in pediatric patients, from newborns to adolescents, who have contracted severe COVID-19 symptoms.
FDA Clears First Prescription Game-Based Treatment Device for Children With ADHD
June 17, 2020
EndeavorRx (Akili Interactive), a prescription-only game-based device, is indicated for use in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.
Projected US Pediatric COVID-19 Numbers Could Overextend Resources
May 04, 2020
The study warned that, with 74 million children in the United States, PICU resources could face concerning strain from COVID-19.
USF Study Reports Pediatric COVID-19 Cases Higher than Expected
April 24, 2020
The study estimates that for each child in the PICU for COVID-19, another 2381 children are infected with the virus.
Protecting Children from COVID-19 Critical for Flattening the Curve
March 24, 2020
Pediatricians stress the importance of understanding the effects of COVID-19 on children.
FDA Approves New Treatment for Pediatric Patients with Any Strain of Hepatitis C
March 20, 2020
The FDA previously approved sofosbuvir and velpatasvir to treat HCV in adults.
More Than One-Third Of US Children Not Following Recommended Vaccine Schedule, Study Finds
March 13, 2020
More than one-third of all children in the United States are not following the recommended vaccine schedule, according to a new study.
Neonatal and Pediatric Pain Management Opioid Stewardship
November 25, 2019
Strategies include nonpharmacologic therapies, nonopioid medications, and opioid rotation.
Sending Prescriptions to School: What Patients Need to Know
August 14, 2019
Survey Finds 45% Of Americans Have Some Doubt About Vaccine Safety
July 19, 2019
Lack of trust in vaccines abetted by online articles and past wrongdoing by the drug industry.